Opinion

Video

The Role of Psychotherapy in Schizophrenia Management

Panelists discuss the vital but often underutilized role of psychotherapy in schizophrenia treatment, emphasizing the need for accessible, tailored interventions such as cognitive behavioral therapy (CBT) for psychosis to complement medication and address persistent functional and cognitive challenges.

In discussing comprehensive treatment strategies for schizophrenia, the conversation turned to the critical—but often under-resourced—role of psychotherapy. While pharmacological interventions remain a central pillar in managing the disorder, participants emphasized that medications alone are not sufficient, particularly when addressing the persistent negative and cognitive symptoms.

Psychotherapy, particularly CBT tailored for psychosis, can play a valuable role in helping patients manage symptoms, reframe thoughts, and develop coping strategies. However, access to trained therapists is severely limited. Even in practices with numerous providers, therapy sessions are constrained by time and resource limitations, resulting in long waiting lists and reduced availability.

The group point out that although specialized forms of CBT can be effective in managing lingering positive symptoms, especially in early- intervention settings, therapists who provide this therapy are few and far between. Standard CBT may not be as beneficial for individuals with schizophrenia as it is for those with mood disorders such as depression or bipolar disorder.

Ultimately, the discussion highlights a major systemic barrier: the shortage of psychotherapy resources tailored to the needs of this patient population. Without adequate access to these nonpharmacologic treatments, many individuals with schizophrenia are left without the full spectrum of care needed for meaningful recovery and quality-of-life improvements. The speakers underscored the necessity of integrating accessible, practical therapeutic approaches alongside medication in order to address day-to-day functional challenges.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Videos
1 KOL is featured in this series
1 KOL is featured in this series
1 KOL is featured in this series
© 2025 MJH Life Sciences

All rights reserved.